Literature DB >> 23442440

Hepatic macrophage activation predicts clinical decompensation in chronic liver disease.

Anthony Rode, Amanda Nicoll, Holger Jon Møller, Lucy Lim, Peter W Angus, Ian Kronborg, Niranjan Arachchi, Alexandra Gorelik, Danny Liew, Konstantin Kazankov, Hendrik Vilstrup, Henning Grønbæk.   

Abstract

Entities:  

Keywords:  CHRONIC LIVER DISEASE; KUPFFER CELL; PORTAL HYPERTENSION

Mesh：

Substances：

Year:  2013        PMID： 23442440     DOI： 10.1136/gutjnl-2012-304135

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  17 in total

Review 1.  Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting.

Authors:  Arjuna Singanayagam; Evangelos Triantafyllou
Journal:  Front Immunol       Date:  2021-04-02       Impact factor: 7.561

2.  Soluble CD163 for Prediction of High-Risk Esophageal Varices and Variceal Hemorrhage in Patients with Liver Cirrhosis.

Authors:  Mohamed Yousri Taher; Abeer El-Hadidi; Assem El-Shendidi; Ahmed Sedky
Journal:  GE Port J Gastroenterol       Date:  2021-07-27

3.  Alcoholic hepatitis: The pivotal role of Kupffer cells.

Authors:  Duminda B Suraweera; Ashley N Weeratunga; Robert W Hu; Stephen J Pandol; Richard Hu
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

4.  The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation.

Authors:  Karen L Thomsen; Francis P Robertson; Peter Holland-Fischer; Brian R Davidson; Rajeshwar P Mookerjee; Holger J Møller; Rajiv Jalan; Henning Grønbæk
Journal:  J Clin Exp Hepatol       Date:  2018-10-05

5.  The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection.

Authors:  Kara W Chew; Lei Hua; Debika Bhattacharya; Adeel A Butt; Lorelei Bornfleth; Raymond T Chung; Janet W Andersen; Judith S Currier
Journal:  Open Forum Infect Dis       Date:  2014-12-03       Impact factor: 3.835

6.  The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients.

Authors:  Thomas Damgaard Sandahl; Sidsel Hyldgaard Støy; Tea Lund Laursen; Sidsel Rødgaard-Hansen; Holger Jon Møller; Søren Møller; Hendrik Vilstrup; Henning Grønbæk
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

7.  Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.

Authors:  F Rainer; A Horvath; T D Sandahl; B Leber; B Schmerboeck; A Blesl; A Groselj-Strele; R E Stauber; P Fickert; P Stiegler; H J Møller; H Grønbaek; V Stadlbauer
Journal:  Aliment Pharmacol Ther       Date:  2017-12-21       Impact factor: 8.171

8.  Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.

Authors:  Jessica L Mueller; Eoin R Feeney; Hui Zheng; Joseph Misdraji; Annie J Kruger; Nadia Alatrakchi; Lindsay Y King; Louis Gelrud; Kathleen E Corey; Raymond T Chung
Journal:  Clin Transl Gastroenterol       Date:  2015-10-08       Impact factor: 4.488

Review 9.  Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure.

Authors:  Marlene Christina Nielsen; Rasmus Hvidbjerg Gantzel; Joan Clària; Jonel Trebicka; Holger Jon Møller; Henning Grønbæk
Journal:  Cells       Date:  2020-05-09       Impact factor: 6.600

10.  Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension.

Authors:  Nikolaj Worm Ørntoft; Michel Blé; Anna Baiges; Jose Ferrusquia; Virginia Hernández-Gea; Fanny Turon; Marta Magaz; Søren Møller; Holger Jon Møller; Juan Carlos Garcia-Pagan; Henning Gronbaek
Journal:  Front Physiol       Date:  2021-06-11       Impact factor: 4.566
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.